{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T12:37:01Z","timestamp":1753274221559,"version":"3.32.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Emerg Med"],"DOI":"10.1186\/s12245-024-00801-3","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T08:51:44Z","timestamp":1735289504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Case report: a case of AL amyloidosis with spontaneous giant retroperitoneal hematoma"],"prefix":"10.1186","volume":"17","author":[{"given":"Yaqi","family":"Sheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huadong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,27]]},"reference":[{"key":"801_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000506617","volume":"143","author":"I Vaxman","year":"2020","unstructured":"Vaxman I, Gertz M. When to Suspect a Diagnosis of Amyloidosis. Acta Haematol. 2020;143:304\u201311.","journal-title":"Acta Haematol"},{"key":"801_CR2","doi-asserted-by":"crossref","unstructured":"Rehab Y AL-Ansari , Ghufran Alofi, Nasser Aljarah, et al. A case report of congenital factor X deficiency in an adult patient. SAGE Open Medical Case Reports 2022;10: 1\u20133.","DOI":"10.1177\/2050313X221116676"},{"key":"801_CR3","doi-asserted-by":"crossref","unstructured":"Masayoshi Souri, TsukasaOsaki, Yuji Shimura, et al. Identification of non-neutrophilralizing anti-factor X autoantibodies in three Japanese cases of autoimmune acquired factor X Deficiency. Haemophilia 2023;29:555\u2013563.","DOI":"10.1111\/hae.14711"},{"key":"801_CR4","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1055\/a-1496-8527","volume":"122","author":"A Ichinose","year":"2022","unstructured":"Ichinose A, Osaki T, Souri M. Autoimmune coagulation factor X deficiency as a rare acquired hemorrhagic disorder: a literature review. Thromb Haemost. 2022;122:320\u20138.","journal-title":"Thromb Haemost"},{"issue":"1","key":"801_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.hemonc.2018.05.002","volume":"12","author":"G Patel","year":"2019","unstructured":"Patel G, Hari P, Szabo A, et al. Acquired factor X deficiency in light-chain (AL) amyloidosis is rare and associated with advanced disease. Hematol Oncol Stem Cell Ther. 2019;12(1):10\u20134.","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"801_CR6","first-page":"1138329","volume":"2021","author":"A Bangolo","year":"2021","unstructured":"Bangolo A, Waykole T, Niazi B, et al. A rare cause of acquired factor X deficiency in an 87-year-old female. Case Rep Hematol. 2021;2021:1138329.","journal-title":"Case Rep Hematol"},{"issue":"11","key":"801_CR7","first-page":"e31473","volume":"14","author":"O Humayun","year":"2022","unstructured":"Humayun O, Durrani T, Ullah R, et al. Post-COVID Factor X Deficiency: A Case Report From Pakistan. Cureus. 2022;14(11):e31473.","journal-title":"Cureus"},{"issue":"5","key":"801_CR8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2169\/internalmedicine.53.0898","volume":"53","author":"M Matsuda","year":"2014","unstructured":"Matsuda M, Katoh N, Ikeda S. Clinical manifestations at diagnosis in Japanese patients with systemic AL amyloidosis: a retrospective study of 202 cases with a special attention to uncommon symptoms. Intern Med. 2014;53(5):403\u201312.","journal-title":"Intern Med"},{"issue":"4","key":"801_CR9","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s12185-019-02811-x","volume":"111","author":"M Arahata","year":"2020","unstructured":"Arahata M, Takamatsu H, Morishita E, et al. Coagulation and fibrinolytic features in AL amyloidosis with abnormal bleeding and usefulness of tranexamic acid. Int J Hematol. 2020;111(4):550\u20138.","journal-title":"Int J Hematol"},{"issue":"6","key":"801_CR10","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.bbapap.2013.02.007","volume":"1834","author":"K Talbot","year":"2013","unstructured":"Talbot K, Meixner SC, Pryzdial EL. Proteolytic modulation of factor Xa-antithrombin complex enhances fibrinolysis in plasma. Biochim Biophys Acta. 2013;1834(6):989\u201395.","journal-title":"Biochim Biophys Acta"},{"key":"801_CR11","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez de Larrea C, Verga L, Morbini P, et al. A practical approach to the diagnosis of systemic amyloidoses. Blood 2015; 125(14): 2239\u201344.","DOI":"10.1182\/blood-2014-11-609883"},{"issue":"24","key":"801_CR12","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH, Merlini G, et al. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016;133(24):2404\u201312.","journal-title":"Circulation"},{"issue":"11","key":"801_CR13","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1038\/leu.2012.100","volume":"26","author":"RL Comenzo","year":"2012","unstructured":"Comenzo RL, Reece D, Palladini G, et al. Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis. Leukemia. 2012;26(11):2317\u201325.","journal-title":"Leukemia"},{"issue":"9","key":"801_CR14","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","volume":"30","author":"S Kumar","year":"2012","unstructured":"Kumar S, Dispenzieri A, Lacy MQ, et al. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol. 2012;30(9):989\u2013958.","journal-title":"J Clin Oncol"},{"issue":"2","key":"801_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s40271-017-0273-5","volume":"11","author":"KL McCausland","year":"2018","unstructured":"McCausland KL, White MK, Guthrie SD, et al. Light Chain (AL) Amyloidosis: The Journey to Diagnosis. Patient. 2018;11(2):207\u201316.","journal-title":"Patient"},{"issue":"7","key":"801_CR16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1080\/07853890.2017.1304649","volume":"49","author":"E Muchtar","year":"2017","unstructured":"Muchtar E, Dispenzieri A, Lacy MQ, et al. Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition. Ann Med. 2017;49(7):545\u201351.","journal-title":"Ann Med"},{"issue":"10","key":"801_CR17","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s12325-015-0250-0","volume":"32","author":"I Lousada","year":"2015","unstructured":"Lousada I, Comenzo RL, Landau H, et al. Light chain amyloidosis: patient experience survey from the amyloidosis research consortium. Adv Ther. 2015;32(10):920\u20138.","journal-title":"Adv Ther"},{"key":"801_CR18","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1111\/trf.15308","volume":"59","author":"O Grottke","year":"2019","unstructured":"Grottke O, Moser O, Farrag A, et al. Plasma-derived factor X therapy for treatment of intracranial bleeding in a patient with Factor X deficiency: a case report. Transfusion. 2019;59:2228\u201333.","journal-title":"Transfusion"},{"key":"801_CR19","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1111\/jth.14985","volume":"18","author":"KL Zimowski","year":"2020","unstructured":"Zimowski KL, McGuinn CE, Abajas YL, et al. Use of plasma-derived factor X concentrate in neonates and infants with congenital factor X deficiency. J Thromb Haemost. 2020;18:2551\u20136.","journal-title":"J Thromb Haemost"},{"key":"801_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12550","volume":"5","author":"JN Huang","year":"2021","unstructured":"Huang JN, Liesner R, Austin SK, et al. Plasma-derived factor X concentrate compassionate use for hereditary factor X deficiency: long-term safety and efficacy in a retrospective data-collection study. Res Pract Thromb Haemost. 2021;5: e12550.","journal-title":"Res Pract Thromb Haemost"},{"key":"801_CR21","doi-asserted-by":"crossref","unstructured":"Jeanette Payne, Glaivy Batsuli, Andrew D, et al. A review of the pharmacokineics, efficacy and safety of high-purity factor X for the prophylactic treatment of hereditary factor X deficiency. Haemophilia 2022;28:523\u2013531.","DOI":"10.1111\/hae.14570"}],"container-title":["International Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-024-00801-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12245-024-00801-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-024-00801-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T09:02:10Z","timestamp":1735290130000},"score":1,"resource":{"primary":{"URL":"https:\/\/intjem.biomedcentral.com\/articles\/10.1186\/s12245-024-00801-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["801"],"URL":"https:\/\/doi.org\/10.1186\/s12245-024-00801-3","relation":{},"ISSN":["1865-1380"],"issn-type":[{"value":"1865-1380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,27]]},"assertion":[{"value":"20 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}